Who is the CEO of BridgeBio?

Neil Kumar is the CEO and founder of BridgeBio.

How many employees does BridgeBio have?

BridgeBio has approximately 820 employees.

Where is BridgeBio headquartered?

The company is headquartered in Palo Alto, California, at 421 Kipling St.

What industry is BridgeBio in?

BridgeBio operates in Biotechnology.

Is BridgeBio still active?

Yes, BridgeBio was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.

How do I sell to BridgeBio?

Research BridgeBio's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details.

Data Surfer

How it works Insights Pricing FAQ Contact Login

BridgeBio

Biotechnology

Palo Alto, United States

820 employees

Founded 2015

bridgebio.com

Verified active February 2, 2026

Key Highlights

BridgeBio focuses on developing transformative medicines for genetic diseases and cancers with clear genetic drivers.
The company is dedicated to discovering, creating, testing, and delivering breakthrough medicines rapidly and safely.
BridgeBio aims to accelerate the development and delivery of novel therapies for underserved patient populations.
Their approach involves a deep understanding of genetic drivers to design targeted and effective treatments.
BridgeBio is committed to bringing innovative solutions to patients facing rare and serious genetic conditions.

About BridgeBio

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. The company is committed to discovering, creating, testing, and delivering breakthrough medicines as quickly and safely as possible.

Leadership Team

Neil Kumar

CEO

Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.

Company Facts

Ownership Private Company

Funding $434M

Why Contact BridgeBio?

BridgeBio is a biotechnology company that develops transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.

Who Should Contact BridgeBio for Business?

BridgeBio operates as a developer of therapeutics for the treatment of genetic diseases and cancers, focusing on discovering, creating, and testing breakthrough medicines.

More Biotechnology Companies

CJ BIO America - Fort Dodge

83 employees

zelle biotechnology pvt. ltd.

View all Biotechnology companies

Frequently Asked Questions

Who is the CEO of BridgeBio?: Neil Kumar is the CEO and founder of BridgeBio.
What does BridgeBio do?: BridgeBio is a biotechnology company that develops transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.
How many employees does BridgeBio have?: BridgeBio has approximately 820 employees.
Where is BridgeBio headquartered?: The company is headquartered in Palo Alto, California, at 421 Kipling St.
What industry is BridgeBio in?: BridgeBio operates in Biotechnology.
When was BridgeBio founded?: BridgeBio was founded in 2015.
Is BridgeBio still active?: Yes, BridgeBio was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to BridgeBio?: Research BridgeBio's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.